Anvendelse af R,S-(+/-)-alfa-liponsyre, R-(+)-alfa-liponsyre, S-(-)-alfa-liponsyre i reduceret eller oxideret form eller deres metabolitter samt deres salte, estere eller amider til fremstilling af rheologiske midler

摘要

The use of R-(+)-~a-liponic acid (IA) S-(-)-~a-liponic acid (IB) the racemic mixt. of (IA)-(IB), in reduced or oxidised form, or their metabolites, salts, esters or amides is claimed for the prodn.of pharmaceuticals and agent. The pharmaceuticals are for the prevention and treatment of diseases or rheological syndromes that are caused by disorders of the rheological characteristics of blood, such as blood viscosity, erythrocyte flexibility and erythrocyte aggregation; for treating diabetes type (II); peripheral or cerebral circulation disorders, esp. in stage II, IIa and IIb (Fontaine): for treating dialysis patient, to protect erythrocytes; for prevention and treatment of tinnitus and hearing loss and for the prevention of essential hypertonia and its sequelae. The agents are for improving the quality of donated blood, when given before the blood donation.